Demetrix Raises $50 Million to Pursue Cannabinoid Biosynthesis
Demetrix Secures $50 Million In Series A Funding To Provide Cannabinoids To Pharmaceutical, Supplement, And Consumer Product Companies Funding Round led by Tuatara Capital with Continued Participation by...